9dreamstudio
Metsera (NASDAQ:MTSR) added ~16% on Tuesday as Wall Street continued to cheer early-stage trial data the company posted for its weight loss candidate MET-233i, which led MTSR shares to rally in the previous session.
Citing topline data from a Phase
